Boston Scientific Corp. closed 6.93% short of its 52-week high of $107.17, which the company achieved on February 5th.

With data as of June 16, 2025, we examine if Boston Scientific Corporation(BSX) is consistently building momentum based on ...

Boston Scientific’s first quarter results were met with a positive market reaction following revenue and profit that ...

Boston Scientific (BSX) stock rose over 2% on Monday after Leerink initiated coverage of the shares with an ‘Outperform’ ...

Boston Scientific's Q1 2025 Endoscopy sales jump 6%, powered by innovation in stents, clips and surgical tools for GI care. Boston Scientific (BSX) might move higher on growing optimism about its ...

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

A federal judge in Boston ordered the National Institutes of Health to restore billions of federal research dollars ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings ...